Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281889 · ClinicalTrials.gov registry record · NA
Proton Craniospinal Irradiation With Bone Sparing to Decrease Growth Decrement From Radiation
A NA study of Brain Tumor, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT03281889 is a NA study of Brain Tumor that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03281889, a NA study of Brain Tumor, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is studying proton radiation as a possible treatment for brain tumor that requires radiation. The radiation involved in this study is: -Proton Radiation
Conditions Studied
Interventions
- RADIATION Proton Beam
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-04 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03281889
The ClinicalTrials.gov registry entry for NCT03281889 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (93% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Proton Beam is the first listed.
NCT03281889 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT03281889 about?
NCT03281889 is a clinical study titled "Proton Craniospinal Irradiation With Bone Sparing to Decrease Growth Decrement From Radiation". This research study is studying proton radiation as a possible treatment for brain tumor that requires radiation. The radiation involved in this study is: -Proton Radiation
What is the current status of trial NCT03281889?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2018-01-04. Estimated completion is 2027-12-31.
What conditions does trial NCT03281889 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT03281889?
The interventions under investigation include: Proton Beam (RADIATION).
Who is sponsoring clinical trial NCT03281889?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03281889 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.